GSK plc
Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
- Careers
Life at AstraZeneca. At AstraZeneca, our purpose is to help...
- Contact Us
If you have questions about a specific medical condition,...
- Medicines
In some cases, health care professionals and patients can...
- Our Company
Our company. We are a global, science-led, patient-focused...
- Pipeline
Pipeline - AstraZeneca - Research-Based BioPharmaceutical...
- Press Releases
Press Releases - AstraZeneca - Research-Based...
- Investor Relations
Investor Relations - AstraZeneca - Research-Based...
- Our Therapy Areas
CVRM (Cardiovascular, Renal and Metabolism) is one of our...
- Careers
It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden and Gaithersburg in Maryland, U.S. [9] AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje.
Our company. We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
Oct 27, 2021 · Important information about the AstraZeneca COVID-19 vaccine. The AstraZeneca COVID-19 vaccine, now called Vaxzevria, is a viral vector vaccine, just like the Johnson & Johnson vaccine. It uses...
Life at AstraZeneca. At AstraZeneca, our purpose is to help patients all over the world by delivering life-changing medicines as one collaborative team.
May 8, 2024 · After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision.
9 hours ago · AstraZeneca raises full-year outlook. ANGLO-SWEDISH drugmaker AstraZeneca on Thursday raised its sales and profit forecast for 2024 and topped analyst expectations for second-quarter revenue, buoyed by demand for its therapies for cancer and rare diseases. Sales in the company's top business, oncology, grew 19 percent at constant currency rates ...
